Cloxacillin antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Cloxacillin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to Antibiotics diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-75-11. BSA-Cloxacillin
2. Anti-Cloxacillin mouse monoclonal antibody
$2709.00
GMP-SMT-75-21. OVA-Cloxacillin
2. Anti-Cloxacillin mouse monoclonal antibody
$2709.00
GMP-SMT-75-31. BSA-Cloxacillin
2. Anti-Cloxacillin human monoclonal antibody
$2709.00
GMP-SMT-75-41. OVA-Cloxacillin
2. Anti-Cloxacillin human monoclonal antibody
$2709.00
GMP-SMT-75-Ag-1BSA-Cloxacillin$756.00
GMP-SMT-75-Ag-2OVA-Cloxacillin$756.00
GMP-SMT-75-Ab-1Anti-Cloxacillin mouse monoclonal antibody$1953.00
GMP-SMT-75-Ab-2Anti-Cloxacillin human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Cloxacillin

Cat No.GMP-SMT-75-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Cloxacillin with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Cloxacillin had been validated with our anti-Hapten antibody Anti-Cloxacillin mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Cloxacillin

Cat No.GMP-SMT-75-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Cloxacillin with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Cloxacillin had been validated with our anti-Hapten antibody Anti-Cloxacillin mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Cloxacillin mouse monoclonal antibody

Cat No.GMP-SMT-75-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)15.00
Products descriptionThe anti-Hapten antibody against hapten Cloxacillin had been validated with our hapten hapten-carrier conjugates BSA-Cloxacillin via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Cloxacillin human monoclonal antibody

Cat No.GMP-SMT-75-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)15.00
Products descriptionThe anti-Hapten antibody against hapten Cloxacillin had been validated with our hapten hapten-carrier conjugates BSA-Cloxacillin via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Biomarker Information


    Basic Orange (BO/CSD) is a cationic dye that falls under the category of basic dyes, specifically belonging to the xanthene family. It is commonly used as a coloring agent in various industrial applications, including textiles, paper production, and plastic manufacturing. BO/CSD possesses a chemical structure characterized by a pyridine ring and an amino group (-NH2), with variations in the substituents attached to the pyridine ring influencing its properties and applications.

    The extensive use of BO/CSD in industrial processes has raised concerns regarding its potential impact on human health and the environment. As a result, there is a growing need to understand its behavior, fate, and potential risks in order to develop appropriate management strategies.

    One particular concern associated with BO/CSD is its potential to contaminate water bodies, both surface water and groundwater. Industrial effluents containing BO/CSD can be discharged into rivers, lakes, and oceans, leading to aquatic pollution. Additionally, improper waste disposal practices or accidental spills can result in the leaching of BO/CSD into soil, potentially contaminating groundwater aquifers.

    BO/CSD is known for its persistence in the environment, which means it can persist for long periods without significant degradation. This persistence increases the likelihood of accumulation in different environmental compartments and raises concerns about its long-term impact on ecosystems. In addition, BO/CSD's resistance to degradation can result in its bioaccumulation in organisms, posing risks to higher trophic levels within the food chain.

    It is essential to monitor the levels of BO/CSD in environmental samples to assess the potential risks it poses to human health and ecosystems. Regular monitoring programs can help identify pollution sources, track trends in contamination, and evaluate the effectiveness of pollution control measures. By measuring BO/CSD concentrations in water, soil, sediment, and biota, regulatory agencies can gain crucial insights into the extent and distribution of contamination.

    Analytical techniques play a crucial role in quantifying BO/CSD concentrations in environmental samples. Spectrophotometry, using absorption or emission measurements, is commonly employed for rapid and cost-effective analysis of BO/CSD levels. High-performance liquid chromatography (HPLC) is another widely used technique that provides accurate and precise measurements of BO/CSD concentrations in complex environmental matrices. Additionally, fluorescence spectroscopy offers the advantage of sensitivity and selectivity for detecting and quantifying BO/CSD in environmental samples.

    To ensure the protection of human health and the environment, it is necessary to implement appropriate management strategies for BO/CSD contamination. This includes promoting sustainable practices in industrial processes, improving wastewater treatment technologies, and implementing strict regulations on the use and disposal of BO/CSD-containing products. Such measures can help minimize the release of BO/CSD into the environment and reduce the potential risks associated with its presence.

    In conclusion, Basic Orange (BO/CSD) is a commonly used cationic dye in various industrial applications. Its potential impact on human health and the environment necessitates careful monitoring and management. Regular monitoring programs and the application of analytical techniques are crucial for assessing contamination levels, identifying pollution sources, and developing effective strategies to mitigate the risks associated with BO/CSD. By adopting sustainable practices and implementing rigorous regulations, it is possible to minimize the environmental and health risks posed by BO/CSD contamination and ensure the long-term well-being of ecosystems and human populations.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.